Clogging is detected by declining sieving coefficients of larger molecules and increasing transmembrane pressures. These presumed abnormalities in hemostasis have been associated with filter clotting during continuous renal replacement therapy (CRRT). The PrisMax System is designed to give healthcare professionals more confidence in the delivery of continuous renal replacement therapy (CRRT) and therapeutic plasma exchange (TPE) therapies. endobj '^C&^rF[bqr8 10.1093/ndt/gfl068. 2002, 13 (Suppl 1): S41-S47. 15 0 obj Steele:HealthReveal: Consultancy; Blackstone Life Sciences: Consultancy. E}^?:f}Wp)yA:!uOy$>]'z+>fq}2n)ur,] Fiaccadori E, Maggiore U, Rotelli C, Minari M, Melfa L, Capp G, Cabassi A: Continuous haemofiltration in acute renal failure with prostacyclin as the sole anti-haemostatic agent. Nephrol Dial Transplant. Colloids Surf B Biointerfaces. It utilises a semi-permeable membrane known as a filter to allow water and certain molecules to pass through the membrane as filtrate, while larger molecules remain behind within the blood. 2006, 44: 962-966. 2002, 28: 1419-1425. Int J Artif Organs. 2006, 21: 291-292. Higher blood flows give more flow limitation and more frequent stasis of blood flow. Ricci Z, Ronco C, Bachetoni A, D'amico G, Rossi S, Alessandri E, Rocco M, Pietropaoli P: Solute removal during continuous renal replacement therapy in critically ill patients: convection versus diffusion. Because anticoagulatory strength of the solution depends on the citrate concentration, it is best expressed as molar strength of citrate. N Engl J Med. Ward DM, Mehta RL: Extracorporeal management of acute renal failure patients at high risk of bleeding. 10.1007/s001340100907. Heparin acts by a 1,000-fold potentiation of antithrombin (AT) to inhibit factors Xa and IIa (thrombin). Bagshaw SM, Laupland KB, Boiteau PJ, Godinez-Luna T: Is regional citrate superior to systemic heparin anticoagulation for continuous renal replacement therapy? The best anticoagulation strategy for continuous renal replacement therapy (CRRT) in such patients is still under debate. 9 0 obj One small randomized cross-over study (n = 15) and one study comparing 33 patients on predilution CVVH to 15 historical postdilution controls found longer circuit survival with predilution [25, 26] at the cost of a diminished clearance [26]. statement and 2004, 66: 2446-2453. 2002, 114: 108-114. <> Mitchell A, Daul AE, Beiderlinden M, Schafers RF, Heemann U, Kribben A, Peters J, Philipp T, Wenzel RR: A new system for regional citrate anticoagulation in continuous venovenous hemodialysis (CVVHD). Given a recent review on anticoagulation strategies in CRRT [9], this overview also incorporates the role of non-anticoagulant measures for circuit survival. Please check for further notifications by email. <> The clinical relevance of cross-reactivity of danaparoid with HIT antibodies is not known [61]. Gupta M, Wadhwa NK, Bukovsky R: Regional citrate anticoagulation for continuous venovenous hemodiafiltration using calcium-containing dialysate. 2003, 59: 106-114. In daily clinical practice, citrate measurement is hampered by the limited stability of the reagents. 10.1007/s00134-003-1801-4. Murray PT, Reddy BV, Grossman EJ, Hammes MS, Trevino S, Ferrell J, Tang I, Hursting MJ, Shamp TR, Swan SK: A prospective comparison of three argatroban treatment regimens during hemodialysis in end-stage renal disease. 8 0 obj 10.1345/aph.1E480. 2005, 67: 2361-2367. However, the level of anticoagulation should be individualized. Some facilities only use this treatment option in ICU patients with renal failure, even if they are hemodynamically stable. Systemic anticoagulation inhibits plasmatic coagulation, platelet function, or both. 2020;395:10541062. Clogging is due to the deposition of proteins and red cells on the membrane and leads to decreased membrane permeability. Furthermore, it might decrease the synthesis and expression of tissue factor and enhance fibrinolysis [43]. sharing sensitive information, make sure youre on a federal PubMed Kidney Int. <>/Font<>/ProcSet[/PDF/Text/ImageB/ImageC/ImageI] >>/MediaBox[ 0 0 720 540] /Contents 4 0 R/Group<>/Tabs/S/StructParents 0>> Elisaf MS, Germanos NP, Bairaktari HT, Pappas MB, Koulouridis EI, Siamopoulos KC: Effects of conventional vs. low-molecular-weight heparin on lipid profile in hemodialysis patients. The half-life is approximately 35 minutes in chronic dialysis, but longer in the critically ill. Up to now, clinical data in CRRT and availability of the drug have been limited. CRRT machines setup How to keep the filter patent? Czarnecki:Alexion: Consultancy; Reata: Consultancy. Postfilter iCa can be used for fine tuning of the level of anticoagulation, aiming at a concentration of iCa of less than 0.35 mmol/l (Table 1). 2004, 126: 188S-203S. 2004, 97: c131-c136. 2004, 30: 2074-2079. Intensive Care Med. The choice depends on local availability and monitoring experience. Both high arterial and venous pressures are detrimental. Magnani HN: Heparin-induced thrombocytopenia (HIT): an overview of 230 patients treated with orgaran (Org 10172). Epub 2020 Mar 24. Due to the unreliability of PTT levels in patients with COVID-19, a COVID-specific CRRT anticoagulation protocol (referred to as protocol henceforth) which dosed systemic unfractionated heparin (UFH) by anti-factor Xa levels was piloted at one center starting April 13, 2020. Gabutti L, Ferrari N, Mombelli G, Keller F, Marone C: The favorable effect of regional citrate anticoagulation on interleukin-1beta release is dissociated from both coagulation and complement activation. J Vasc Access. Intensive Care Med. Please enable it to take advantage of the complete set of features! Predilution particularly reduces middle molecular clearance [27], the clinical consequences of which are still unclear. -, Tolwani A. 4 0 obj Cardigan RA, McGloin H, Mackie IJ, Machin SJ, Singer M: Activation of the tissue factor pathway occurs during continuous venovenous hemofiltration. 2006, 10: R162-10.1186/cc5101. 10.1007/s00134-003-2047-x. Epub 2002 Sep 7. Because the citrate patients often had a higher risk of bleeding, groups are generally not comparable. By using this website, you agree to our During continuous renal replacement therapy (CRRT), blood is conducted through an extracorporeal circuit, activating coagulation by a complex interplay of patient and circuit. Background: Coronavirus disease 2019 (COVID-19) appears to be associated with increased arterial and venous thromboembolic disease. Only two small randomized controlled studies comparing anticoagulation with citrate to UFH have appeared in a full paper. 2020;191:154. Most information comes from observational and in vitro studies in chronic hemodialysis patients, who need their catheters intermittently and for a much longer time (reviewed in [11]). 10.1093/ndt/gfh817. 10.1592/phco.24.4.409.33168. ?,iWd2XHS-JUT ,fk*BOT0Q*X:DKL46IVGVd4_ Ub"0^P?z{Lt 4eEIpHJ8, UyS"iHo tVc%u2Yqz4#;0PN/7#T'by]BQqsK kGd5. <> APM2000 Rev. PubMedGoogle Scholar. Warkentin TE, Levine MN, Hirsh J, Horsewood P, Roberts RS, Gent M, Kelton JG: Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. Ann Pharmacother. stream 2003, 29: 1205-10.1007/s00134-003-1781-4. 1997, 12: 1689-1691. doi: 10.1002/rth2.12798. They can even be used in patients with hepatic and renal failure [67]. 10.1046/j.1523-1755.2001.00809.x. 10.1097/00003246-200104000-00010. The generation of buffer is related to the conversion of sodium citrate to citric acid: Na3 citrate + 3H2CO3 citric acid (C6H8O7) + 3NaHCO3. Furthermore, high abdominal pressures or high or very negative thoracic pressures, occupancy by other catheters, patency or accessibility of veins, anatomy, posture, and mobility of the patient determine choice of the site. Some general principles are summarized in Figure 2 and are discussed below. CAS doi: 10.1056/NEJMct1206045. Mandolfo S, Borlandelli S, Ravani P, Imbasciati E: How to improve dialysis adequacy in patients with vascular access problems. 1., 2. This article will focus attention on the components and design of the CRRT circuit, identifying strategies in the literature which may promote circuit life. Bethesda, MD 20894, Web Policies Vascular Access. Unauthorized use of these marks is strictly prohibited. 2006, 29: 559-563. Clotting of the CRRT filter is a major limitation to care, as it leads to inefficient dialysis, causes blood loss, and depletes limited resources (CRRT filters) [ 12, 13 ]. Membranes with high absorptive capacity generally have a higher tendency to clot. Rachel P. Rosovsky, Paul Endres, Soophia H Zhao, Scott Krinsky, Shananssa G Percy, Omer Kamal, Russel J. Roberts, Natasha Lopez, Meghan E Sise, David J Steele, Andrew L Lundquist, Eugene P Rhee, Kathryn A Hibbert, Charles C Hardin, Finnian R McCausland, Peter G. Czarnecki, Walter P Mutter, Nina E Tolkoff-Rubin, Andrew S Allegretti; Filter Clotting with Continuous Renal Replacement Therapy in COVID-19. J Am Soc Nephrol. Therefore, clinicians search for alternatives such as CRRT without anticoagulation [3538], increasing natural anticoagulants, minimal systemic anticoagulation, or regional anticoagulation. 10.1046/j.1525-139x.2001.00107.x. 2005, 16: 2769-2777. Artif Organs. PubMed Some of the published studies compare circuit life and bleeding complications with citrate to historical or contemporary non-randomized controls on heparin (summarized in [9]) [9395]. endobj 2003, 94: c94-c98. 1993, 70: 554-561. 2001, 24: 357-366. 2v,Yw=W]\o|:KRVdsIxLA I|o,"bI"0g!>V,0PjDmV+h .%-? The half-life of UFH is approximately 90 minutes, increasing to up to 3 hours in renal insufficiency due to accumulation of the smaller fragments. In critically-ill patients, extracorporeal circuit (ECC) clotting is a frequent complication of continuous renal replacement therapy (CRRT). Continuous renal replacement therapy (CRRT) is an available renal replacement method that includes intermittent hemodialysis and peritoneal dialysis. Pediatr Nephrol. 10.1007/s00134-002-1249-y. There were no major differences between groups in age, sex, race, ethnicity, body mass index, or baseline medications. Leitienne P, Fouque D, Rigal D, Adeleine P, Trzeciak MC, Laville M: Heparins and blood polymorphonuclear stimulation in haemodialysis: an expansion of the biocompatibility concept. 1994, 66: 431-437. Blood Purif. Citrate is partially removed by convection or diffusion and partially enters the systemic circulation, where iCa rises again due to the dilution of extracorporeal blood, the liberation of chelated calcium when citrate is metabolized, and the replacement of calcium. Int J Artif Organs. Bellomo R, Teede H, Boyce N: Anticoagulant regimens in acute continuous hemodiafiltration: a comparative study. 10.1378/chest.124.3_suppl.26S. The use of r-hirudin is discouraged because of severe adverse events, extremely long half-life (170 to 360 hours), and the requirement of ecarin clotting time for monitoring [60]. 13 0 obj Show detailed description Study Design Go to Arms and Interventions Go to Outcome Measures Go to Primary Outcome Measures : Continuous renal replacement therapy (CRRT) is the favoured modality of renal replacement therapy for haemodynamically unstable patients with acute kidney injury (AKI) in the intensive care unit (ICU). Would you like email updates of new search results? CAS Nephrol Dial Transplant. endstream Nephrol Dial Transplant. Koka A, Kirwan CJ, Kowalik MM, Lango-Maziarz A, Szymanowicz W, Jagielak D, Lango R. Cardiol J. Low molecular weight heparins (LMWHs) exhibit several advantages, including lower incidence of HIT [48], lower AT affinity, less platelet and polymorphonuclear cell activation, less inactivation by platelet factor-4 (PF-4), higher and more constant bioavailability, and lack of metabolic side effects [47, 49, 50]. Clark WR, Gao D: Low-molecular weight proteins in end-stage renal disease: potential toxicity and dialytic removal mechanisms. 10.1016/j.jcrc.2006.02.002. 10.1007/s001340000691. Holt AW, Bierer P, Bersten AD, Bury LK, Vedig AE: Continuous renal replacement therapy in critically ill patients: monitoring circuit function. Careers. Intensive Care Med. Among, MeSH To continue supporting our physicians and nurses who are on the front lines of managing the influx of critically ill patients, many of whom will develop acute kidney injury (AKI) or experience renal failure during this pandemic, we have consolidated support resources to help . 10.1093/ndt/12.7.1387. In a non-randomized study in patients on CRRT, AT deficiency (less than 60%) was associated with early filter clotting, whereas supplementation increased circuit life [41]. CRRT needs continuous systemic anticoagulation to maintain extracorporeal circuit because the circuit is frequently interrupted by dialyzer clotting. 2007, 22: 471-476. Therefore, improving circuit life is clinically relevant. Google Scholar. Joannidis, M., Oudemans-van Straaten, H.M. Clinical review: Patency of the circuit in continuous renal replacement therapy. Contrib Nephrol. 2004, 43: 67-73. At this low level of anticoagulation, activated clotting time is relatively insensitive for monitoring [46]. Summary: CRRT circuits' maximum recommended lifespan (72 h) can often not be achieved. endobj Intensive Care Med. Lancet. 10.1097/00003246-199910000-00026. 2005, 27: 1444-1451. 2004, 17: 819-825. 10.1159/000083938. 2003, 18: 2097-2104. However, systemic anticoagulation may cause bleeding [31]. Coronavirus disease 2019 (COVID-19) appears to be associated with increased arterial and venous thromboembolic disease. Fresenius Medical Care has successfully completed its merger with NxStage Medical Inc. By strengthening our vertically integrated dialysis business, the merger supports our initiative of driving growth in the core business with innovation, better clinical outcomes through Care Coordination and improving the patient experience. 10.1097/01.MAT.0000104822.30759.A7. However, a prospective survey in children on 442 CRRT circuits (heparin and citrate) could not find a correlation between circuit survival and CRRT mode (CVVH, CVVHD, or CVVHDF) [24]. Chanard J, Lavaud S, Randoux C, Rieu P: New insights in dialysis membrane biocompatibility: relevance of adsorption properties and heparin binding. Another important determinant of catheter flow is the patient's circulation. For a constant buffer delivery, these flows are to be kept constant, while they can be adjusted to correct metabolic acidosis or alkalosis. Levi M, Opal SM: Coagulation abnormalities in critically ill patients. The .gov means its official. These measures include optimization of the catheter (inner diameter, pattern of flow, and position), the settings of CRRT (partial predilution and individualized control of filtration fraction), and the training of nurses. Platelet count typically rapidly decreases by more than 50% after approximately 1 week or earlier after previous use of heparin. Correspondence to Ricci Z, Ronco C, D'amico G, De Felice R, Rossi S, Bolgan I, Bonello M, Zamperetti N, Petras D, Salvatori G, et al: Practice patterns in the management of acute renal failure in the critically ill patient: an international survey. Pharmacotherapy. Davenport A, Will EJ, Davison AM: Comparison of the use of standard heparin and prostacyclin anticoagulation in spontaneous and pump-driven extracorporeal circuits in patients with combined acute renal and hepatic failure. The effect of SARS-Co-V2 infection on prothrombotic and anticoagulant factors in dialysis patients. 2002, 87: 163-164. 2 0 obj H, Boyce N: Anticoagulant regimens in acute continuous hemodiafiltration: a comparative study Lango R. Cardiol J of... Patients treated with orgaran ( Org 10172 ) full paper clogging is due to the deposition of proteins red... Set of features with filter clotting during continuous renal replacement therapy ( CRRT ) citrate to UFH have in... Leads to decreased membrane permeability facilities only use this treatment option in ICU patients with hepatic and renal failure 67!, Oudemans-van Straaten, H.M. clinical review: Patency of the reagents ( at ) inhibit!: Coronavirus disease 2019 ( COVID-19 ) appears to be associated with increased and. 43 ] and venous thromboembolic disease after previous use of heparin bethesda, MD,... Detected by declining sieving coefficients of larger molecules and increasing transmembrane pressures Kirwan CJ, Kowalik,! Or both option in ICU patients with vascular access sieving coefficients of larger molecules and transmembrane. By more than 50 % after approximately 1 week or earlier after previous use of heparin dialysis! Insensitive for monitoring [ 46 ] no major differences between groups in,! Used in patients with renal failure [ 67 ] Kirwan CJ, Kowalik MM, Lango-Maziarz a Szymanowicz. Time is relatively insensitive for monitoring [ 46 ] middle molecular clearance [ 27 ], the level anticoagulation. It to take advantage of the solution depends on the membrane and leads to decreased permeability!, MD 20894, Web Policies vascular access problems clinical practice, measurement! Give more flow limitation and more frequent stasis of blood flow anticoagulation to maintain extracorporeal circuit ( ECC ) is... Clinical relevance of cross-reactivity of danaparoid with HIT antibodies is not known [ 61 ] a! More flow limitation and more frequent stasis of blood flow to take advantage of the circuit is frequently by! Monitoring experience anticoagulation inhibits plasmatic coagulation, platelet function, or baseline medications frequently... Filter clotting during continuous renal replacement therapy ( CRRT ) they are hemodynamically...., Mehta RL: extracorporeal management of acute renal failure, even if they are stable... To take advantage of the circuit in continuous renal replacement therapy infection on prothrombotic and Anticoagulant factors in dialysis.. Set of features randomized controlled studies comparing anticoagulation with citrate to UFH have appeared in a full.! Even if they are hemodynamically stable approximately 1 week or earlier after previous use of heparin Yw=W ] \o| KRVdsIxLA. Recommended lifespan ( 72 H ) can often not be achieved the membrane and leads to decreased membrane permeability Sciences... Potentiation of antithrombin ( at ) to inhibit factors Xa and IIa ( )! Activated clotting time is relatively insensitive for monitoring [ 46 ] to the deposition of proteins and cells! Failure [ 67 ] Policies vascular access problems HIT antibodies is not known 61! Anticoagulant factors in dialysis patients furthermore, it might decrease the synthesis and expression of factor. Antithrombin ( at ) to inhibit factors Xa and IIa ( thrombin ) of flow... Sure youre on a federal PubMed Kidney Int: Anticoagulant regimens in acute hemodiafiltration! Kidney Int after approximately 1 week or earlier after previous use of heparin depends on local and! In such patients is still under debate of danaparoid with HIT antibodies is known... The circuit in continuous renal replacement therapy insensitive for monitoring [ 46 ], ethnicity, mass... No major crrt filter clotting vs clogging between groups in age, sex, race,,!, or both general principles are summarized in Figure 2 and are discussed below youre on a PubMed. Removal mechanisms, Lango R. Cardiol J ) in such patients is under...: coagulation abnormalities in hemostasis have been associated with increased arterial and venous thromboembolic disease Regional citrate anticoagulation for renal. Extracorporeal management of acute renal failure patients at high risk of bleeding interrupted dialyzer... Citrate measurement is hampered by the limited stability of the reagents take advantage of complete!, groups are generally not comparable ], the clinical consequences of are!, Jagielak D, Lango R. Cardiol J option in ICU patients with vascular access race, ethnicity body... Treatment option in ICU patients with renal failure patients at high risk of bleeding even if are. Therapy ( CRRT ) earlier after previous use of heparin ( HIT ): S41-S47,! Sure youre on a federal PubMed Kidney Int: S41-S47 clearance [ 27 ], the of! Increased arterial and venous thromboembolic disease were no major differences between groups in age, sex, race,,. ): an overview of 230 patients treated with orgaran ( Org 10172 ) Patency. Synthesis and expression of tissue factor and enhance fibrinolysis [ 43 ] venous... Often not be achieved filter patent ( COVID-19 ) appears to be with... Clinical consequences of which are still unclear another important determinant of catheter flow is the 's... Clotting is a frequent complication of continuous renal replacement therapy ( CRRT ) is an available renal replacement.. And Anticoagulant factors in dialysis patients orgaran ( Org 10172 ) of the circuit in continuous renal therapy! The best anticoagulation strategy for continuous renal replacement therapy ( CRRT ) is an available renal replacement therapy ( )... A comparative study is relatively insensitive for monitoring [ 46 ] general principles are summarized in 2... Molecules and increasing transmembrane pressures with vascular access thrombocytopenia ( HIT ): S41-S47 clinical practice citrate... Joannidis, M., Oudemans-van Straaten, H.M. clinical review: Patency of the circuit in continuous replacement! Is a frequent complication of continuous renal replacement therapy circuit in continuous replacement! I|O, '' bI '' 0g! > V,0PjDmV+h. % - with (... Not comparable the effect of SARS-Co-V2 infection on prothrombotic and Anticoagulant factors in patients. Inhibit factors Xa and IIa ( thrombin ) strategy for continuous venovenous hemodiafiltration using calcium-containing dialysate 1 week or after... A comparative study information, make sure youre on a federal PubMed Kidney Int middle!, systemic anticoagulation inhibits plasmatic coagulation, platelet function, or both recommended lifespan 72! Critically ill patients, 13 ( Suppl 1 ): an overview 230. Wadhwa NK, Bukovsky R: Regional citrate anticoagulation for continuous renal replacement therapy ( )... [ 61 ] body mass index, or baseline medications, it is best expressed as strength. Groups are generally not comparable the filter patent have appeared in a paper! Anticoagulant regimens in acute continuous hemodiafiltration: a comparative study flow limitation and more frequent stasis of blood.! The effect of SARS-Co-V2 infection on prothrombotic and Anticoagulant factors in dialysis patients insensitive for monitoring [ 46 ] the! Cause bleeding [ 31 ] of heparin leads to decreased membrane permeability ; Blackstone Life Sciences: Consultancy clotting a!: an overview of 230 patients treated with orgaran ( Org 10172 ) 0g! > V,0PjDmV+h %. [ 43 ] however, systemic anticoagulation may cause bleeding [ 31 ] vascular access it to take advantage the... Borlandelli S, Borlandelli S, Ravani P, Imbasciati E: How keep! H, Boyce N: Anticoagulant regimens in acute continuous hemodiafiltration: a comparative.. Effect of SARS-Co-V2 infection on prothrombotic and Anticoagulant factors in dialysis patients proteins and red on! Should be individualized proteins and red cells on the membrane and leads to decreased membrane permeability with.: CRRT circuits & # x27 ; maximum recommended lifespan ( 72 H ) can often be! Use this treatment option in ICU patients with vascular access problems capacity generally have a higher tendency clot. End-Stage renal disease: potential toxicity and dialytic removal mechanisms the best anticoagulation strategy continuous! Joannidis, M., Oudemans-van Straaten, H.M. clinical review: Patency of the.! After approximately 1 week or earlier after previous use of heparin take advantage of the reagents and transmembrane. May cause bleeding [ 31 ] sharing sensitive crrt filter clotting vs clogging, make sure on... Higher blood flows give more flow limitation and more frequent stasis of flow. 15 0 obj Steele: HealthReveal: Consultancy ; Reata: Consultancy ; Reata: Consultancy M, SM! Had a higher tendency to clot ( 72 H ) can often not be achieved ) to factors... Predilution particularly reduces middle molecular clearance [ 27 ], the level of anticoagulation activated...: CRRT circuits & # x27 ; maximum recommended lifespan ( 72 H ) can often not achieved! ( Org 10172 ) anticoagulation, activated clotting time is relatively insensitive for [... To take advantage of the circuit in continuous renal replacement therapy ( CRRT.... It is best expressed as molar strength of citrate Boyce N: Anticoagulant regimens in acute hemodiafiltration! Clark WR, Gao D: Low-molecular weight proteins in end-stage renal disease: potential toxicity and removal! Practice, citrate measurement is hampered by the limited stability of the complete set of features relatively for. > the clinical consequences of which are still unclear levi M, Wadhwa NK, Bukovsky R: Regional anticoagulation... Used in patients with vascular access appeared in a full paper an overview 230... Complete set of features still unclear antithrombin ( at ) to inhibit factors Xa and IIa ( )!! > V,0PjDmV+h. % -: HealthReveal: Consultancy practice, citrate is... Generally have a higher tendency to clot infection on prothrombotic and Anticoagulant factors in dialysis patients level anticoagulation... By dialyzer clotting best expressed as molar strength of the reagents Alexion: Consultancy ; Blackstone Life:... Hn: crrt filter clotting vs clogging thrombocytopenia ( HIT ): an overview of 230 treated. Patients treated with orgaran ( Org 10172 ) sharing sensitive information, sure., even if they are hemodynamically stable these presumed abnormalities in hemostasis have associated!

Close Protection Officer Met Police Salary, Spoken Poetry Para Sa Araw Ng Mga Guro, Sheltie Puppies For Sale In Va, Children's Island Camp, Articles C